190 related articles for article (PubMed ID: 37316674)
1. Improving Blood Monocyte Energy Metabolism Enhances Its Ability to Phagocytose Amyloid-β and Prevents Alzheimer's Disease-Type Pathology and Cognitive Deficits.
Liu ZH; Bai YD; Yu ZY; Li HY; Liu J; Tan CR; Zeng GH; Tu YF; Sun PY; Jia YJ; He JC; Wang YJ; Bu XL
Neurosci Bull; 2023 Dec; 39(12):1775-1788. PubMed ID: 37316674
[TBL] [Abstract][Full Text] [Related]
2. Monocytes release cystatin F dimer to associate with Aβ and aggravate amyloid pathology and cognitive deficits in Alzheimer's disease.
Li Q; Li B; Liu L; Wang KJ; Liu MY; Deng Y; Li Z; Zhao WD; Wu LY; Chen YH; Zhang K
J Neuroinflammation; 2024 May; 21(1):125. PubMed ID: 38730470
[TBL] [Abstract][Full Text] [Related]
3. Polysaccharide Krestin Prevents Alzheimer's Disease-type Pathology and Cognitive Deficits by Enhancing Monocyte Amyloid-β Processing.
Chen SH; He CY; Shen YY; Zeng GH; Tian DY; Cheng Y; Xu MY; Fan DY; Tan CR; Shi AY; Bu XL; Wang YJ
Neurosci Bull; 2022 Mar; 38(3):290-302. PubMed ID: 34611829
[TBL] [Abstract][Full Text] [Related]
4. Chronic Toxoplasma gondii infection enhances β-amyloid phagocytosis and clearance by recruited monocytes.
Möhle L; Israel N; Paarmann K; Krohn M; Pietkiewicz S; Müller A; Lavrik IN; Buguliskis JS; Schott BH; Schlüter D; Gundelfinger ED; Montag D; Seifert U; Pahnke J; Dunay IR
Acta Neuropathol Commun; 2016 Mar; 4():25. PubMed ID: 26984535
[TBL] [Abstract][Full Text] [Related]
5. Far infrared light irradiation enhances Aβ clearance via increased exocytotic microglial ATP and ameliorates cognitive deficit in Alzheimer's disease-like mice.
Li Q; Peng J; Luo Y; Zhou J; Li T; Cao L; Peng S; Zuo Z; Wang Z
J Neuroinflammation; 2022 Jun; 19(1):145. PubMed ID: 35701825
[TBL] [Abstract][Full Text] [Related]
6. Methods to monitor monocytes-mediated amyloid-beta uptake and phagocytosis in the context of adjuvanted immunotherapies.
Hallé M; Tribout-Jover P; Lanteigne AM; Boulais J; St-Jean JR; Jodoin R; Girouard MP; Constantin F; Migneault A; Renaud F; Didierlaurent AM; Mallett CP; Burkhart D; Pilorget A; Palmantier R; Larocque D
J Immunol Methods; 2015 Sep; 424():64-79. PubMed ID: 26002154
[TBL] [Abstract][Full Text] [Related]
7. Human umbilical cord blood-derived monocytes improve cognitive deficits and reduce amyloid-β pathology in PSAPP mice.
Darlington D; Li S; Hou H; Habib A; Tian J; Gao Y; Ehrhart J; Sanberg PR; Sawmiller D; Giunta B; Mori T; Tan J
Cell Transplant; 2015; 24(11):2237-50. PubMed ID: 26230612
[TBL] [Abstract][Full Text] [Related]
8. Amyloid-beta uptake by blood monocytes is reduced with ageing and Alzheimer's disease.
Chen SH; Tian DY; Shen YY; Cheng Y; Fan DY; Sun HL; He CY; Sun PY; Bu XL; Zeng F; Liu J; Deng J; Xu ZQ; Chen Y; Wang YJ
Transl Psychiatry; 2020 Dec; 10(1):423. PubMed ID: 33293506
[TBL] [Abstract][Full Text] [Related]
9. A novel role for osteopontin in macrophage-mediated amyloid-β clearance in Alzheimer's models.
Rentsendorj A; Sheyn J; Fuchs DT; Daley D; Salumbides BC; Schubloom HE; Hart NJ; Li S; Hayden EY; Teplow DB; Black KL; Koronyo Y; Koronyo-Hamaoui M
Brain Behav Immun; 2018 Jan; 67():163-180. PubMed ID: 28860067
[TBL] [Abstract][Full Text] [Related]
10. Peritoneal dialysis reduces amyloid-beta plasma levels in humans and attenuates Alzheimer-associated phenotypes in an APP/PS1 mouse model.
Jin WS; Shen LL; Bu XL; Zhang WW; Chen SH; Huang ZL; Xiong JX; Gao CY; Dong Z; He YN; Hu ZA; Zhou HD; Song W; Zhou XF; Wang YZ; Wang YJ
Acta Neuropathol; 2017 Aug; 134(2):207-220. PubMed ID: 28477083
[TBL] [Abstract][Full Text] [Related]
11. Quantitative proteomics reveals that PEA15 regulates astroglial Aβ phagocytosis in an Alzheimer's disease mouse model.
Lv J; Ma S; Zhang X; Zheng L; Ma Y; Zhao X; Lai W; Shen H; Wang Q; Ji J
J Proteomics; 2014 Oct; 110():45-58. PubMed ID: 25108202
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic effects of glatiramer acetate and grafted CD115⁺ monocytes in a mouse model of Alzheimer's disease.
Koronyo Y; Salumbides BC; Sheyn J; Pelissier L; Li S; Ljubimov V; Moyseyev M; Daley D; Fuchs DT; Pham M; Black KL; Rentsendorj A; Koronyo-Hamaoui M
Brain; 2015 Aug; 138(Pt 8):2399-422. PubMed ID: 26049087
[TBL] [Abstract][Full Text] [Related]
13. Intravenous infusion of monocytes isolated from 2-week-old mice enhances clearance of Beta-amyloid plaques in an Alzheimer mouse model.
Hohsfield LA; Humpel C
PLoS One; 2015; 10(4):e0121930. PubMed ID: 25830951
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of Smad3 in macrophages promotes Aβ efflux from the brain and thereby ameliorates Alzheimer's pathology.
Xu L; Pan CL; Wu XH; Song JJ; Meng P; Li L; Wang L; Zhang Z; Zhang ZY
Brain Behav Immun; 2021 Jul; 95():154-167. PubMed ID: 33737172
[TBL] [Abstract][Full Text] [Related]
15. Early monocyte modulation by the non-erythropoietic peptide ARA 290 decelerates AD-like pathology progression.
Al-Onaizi MA; Thériault P; Lecordier S; Prefontaine P; Rivest S; ElAli A
Brain Behav Immun; 2022 Jan; 99():363-382. PubMed ID: 34343617
[TBL] [Abstract][Full Text] [Related]
16. C5aR agonist enhances phagocytosis of fibrillar and non-fibrillar Aβ amyloid and preserves memory in a mouse model of familial Alzheimer's disease.
Panayiotou E; Fella E; Andreou S; Papacharalambous R; Gerasimou P; Costeas P; Angeli S; Kousiappa I; Papacostas S; Kyriakides T
PLoS One; 2019; 14(12):e0225417. PubMed ID: 31809505
[TBL] [Abstract][Full Text] [Related]
17. Administration of anti-ERMAP antibody ameliorates Alzheimer's disease in mice.
Liu H; Zhao J; Lin Y; Su M; Lai L
J Neuroinflammation; 2021 Nov; 18(1):268. PubMed ID: 34774090
[TBL] [Abstract][Full Text] [Related]
18. Oral administration of Pantoea agglomerans-derived lipopolysaccharide prevents metabolic dysfunction and Alzheimer's disease-related memory loss in senescence-accelerated prone 8 (SAMP8) mice fed a high-fat diet.
Kobayashi Y; Inagawa H; Kohchi C; Kazumura K; Tsuchiya H; Miwa T; Okazaki K; Soma GI
PLoS One; 2018; 13(6):e0198493. PubMed ID: 29856882
[TBL] [Abstract][Full Text] [Related]
19. Bone-Marrow-Derived Microglia-Like Cells Ameliorate Brain Amyloid Pathology and Cognitive Impairment in a Mouse Model of Alzheimer's Disease.
Kawanishi S; Takata K; Itezono S; Nagayama H; Konoya S; Chisaki Y; Toda Y; Nakata S; Yano Y; Kitamura Y; Ashihara E
J Alzheimers Dis; 2018; 64(2):563-585. PubMed ID: 29914020
[TBL] [Abstract][Full Text] [Related]
20. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models.
Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S
Elife; 2020 Jun; 9():. PubMed ID: 32510331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
